Cargando…
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents
AIM: Intermittent hypoxia (IH) is considered to be a major contributor to obstructive sleep apnoea-related cardiovascular consequences. The present meta-analysis aimed to assess the effects of IH on cardiac remodelling, function and infarct size after myocardial ischaemia across different rodent spe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171537/ https://www.ncbi.nlm.nih.gov/pubmed/35418489 http://dx.doi.org/10.1183/16000617.0269-2021 |
_version_ | 1784721689208160256 |
---|---|
author | Belaidi, Elise Khouri, Charles Harki, Olfa Baillieul, Sébastien Faury, Gilles Briançon-Marjollet, Anne Pépin, Jean-Louis Arnaud, Claire |
author_facet | Belaidi, Elise Khouri, Charles Harki, Olfa Baillieul, Sébastien Faury, Gilles Briançon-Marjollet, Anne Pépin, Jean-Louis Arnaud, Claire |
author_sort | Belaidi, Elise |
collection | PubMed |
description | AIM: Intermittent hypoxia (IH) is considered to be a major contributor to obstructive sleep apnoea-related cardiovascular consequences. The present meta-analysis aimed to assess the effects of IH on cardiac remodelling, function and infarct size after myocardial ischaemia across different rodent species and IH severities. METHODS AND RESULTS: Relevant articles from PubMed, Embase and Web of Science were screened. We performed a random effect meta-analysis to assess the effect of IH on myocardium in rodents by using standardised mean difference (SMD). Studies using rodents exposed to IH and outcomes related to cardiac remodelling, contractile function and response to myocardial ischaemia–reperfusion were included. 5217 articles were screened and 92 were included, demonstrating that IH exposure induced cardiac remodelling, characterised by cardiomyocyte hypertrophy (cross-sectional area: SMD=2.90, CI (0.82–4.98), I(2)=94.2%), left ventricular (LV) dilation (LV diameter: SMD=0.64, CI (0.18–1.10), I(2)=88.04%), interstitial fibrosis (SMD=5.37, CI (3.22–7.53), I(2)=94.8) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick end labelling: SMD=6.70, CI (2.96–10.44), I(2)=95.9). These structural changes were accompanied by a decrease in LV ejection fraction (SMD=−1.82, CI (−2.52–−1.12), I(2)=94.22%). Importantly, most of the utilised IH protocols mimicked extremely severe hypoxic disease. Concerning infarct size, meta-regression analyses highlighted an ambivalent role of IH, depending on its severity. Indeed, IH exposure with inspiratory oxygen fraction (F(IO(2))) <7% was associated with an increase in infarct size, whereas a reduced infarct size was reported for F(IO(2)) levels above 10%. Heterogeneity between studies, small study effect and poor reporting of methods in included articles limited the robustness of the meta-analysis findings. CONCLUSION: This meta-analysis demonstrated that severe IH systematically induces cardiac remodelling and contractile dysfunction in rodents, which might trigger or aggravate chronic heart failure. Interestingly, this meta-analysis showed that, depending on stimulus severity, IH exhibits both protective and aggravating effects on infarct size after experimental ischaemia–reperfusion procedures. |
format | Online Article Text |
id | pubmed-9171537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-91715372022-06-08 Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents Belaidi, Elise Khouri, Charles Harki, Olfa Baillieul, Sébastien Faury, Gilles Briançon-Marjollet, Anne Pépin, Jean-Louis Arnaud, Claire Eur Respir Rev Reviews AIM: Intermittent hypoxia (IH) is considered to be a major contributor to obstructive sleep apnoea-related cardiovascular consequences. The present meta-analysis aimed to assess the effects of IH on cardiac remodelling, function and infarct size after myocardial ischaemia across different rodent species and IH severities. METHODS AND RESULTS: Relevant articles from PubMed, Embase and Web of Science were screened. We performed a random effect meta-analysis to assess the effect of IH on myocardium in rodents by using standardised mean difference (SMD). Studies using rodents exposed to IH and outcomes related to cardiac remodelling, contractile function and response to myocardial ischaemia–reperfusion were included. 5217 articles were screened and 92 were included, demonstrating that IH exposure induced cardiac remodelling, characterised by cardiomyocyte hypertrophy (cross-sectional area: SMD=2.90, CI (0.82–4.98), I(2)=94.2%), left ventricular (LV) dilation (LV diameter: SMD=0.64, CI (0.18–1.10), I(2)=88.04%), interstitial fibrosis (SMD=5.37, CI (3.22–7.53), I(2)=94.8) and apoptosis (terminal deoxynucleotidyl transferase dUTP nick end labelling: SMD=6.70, CI (2.96–10.44), I(2)=95.9). These structural changes were accompanied by a decrease in LV ejection fraction (SMD=−1.82, CI (−2.52–−1.12), I(2)=94.22%). Importantly, most of the utilised IH protocols mimicked extremely severe hypoxic disease. Concerning infarct size, meta-regression analyses highlighted an ambivalent role of IH, depending on its severity. Indeed, IH exposure with inspiratory oxygen fraction (F(IO(2))) <7% was associated with an increase in infarct size, whereas a reduced infarct size was reported for F(IO(2)) levels above 10%. Heterogeneity between studies, small study effect and poor reporting of methods in included articles limited the robustness of the meta-analysis findings. CONCLUSION: This meta-analysis demonstrated that severe IH systematically induces cardiac remodelling and contractile dysfunction in rodents, which might trigger or aggravate chronic heart failure. Interestingly, this meta-analysis showed that, depending on stimulus severity, IH exhibits both protective and aggravating effects on infarct size after experimental ischaemia–reperfusion procedures. European Respiratory Society 2022-04-13 /pmc/articles/PMC9171537/ /pubmed/35418489 http://dx.doi.org/10.1183/16000617.0269-2021 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Reviews Belaidi, Elise Khouri, Charles Harki, Olfa Baillieul, Sébastien Faury, Gilles Briançon-Marjollet, Anne Pépin, Jean-Louis Arnaud, Claire Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents |
title | Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents |
title_full | Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents |
title_fullStr | Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents |
title_full_unstemmed | Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents |
title_short | Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents |
title_sort | cardiac consequences of intermittent hypoxia: a matter of dose? a systematic review and meta-analysis in rodents |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171537/ https://www.ncbi.nlm.nih.gov/pubmed/35418489 http://dx.doi.org/10.1183/16000617.0269-2021 |
work_keys_str_mv | AT belaidielise cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT khouricharles cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT harkiolfa cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT baillieulsebastien cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT faurygilles cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT brianconmarjolletanne cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT pepinjeanlouis cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents AT arnaudclaire cardiacconsequencesofintermittenthypoxiaamatterofdoseasystematicreviewandmetaanalysisinrodents |